XML 83 R6.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Consolidated Statements of Changes in Equity - USD ($)
$ in Millions
Total
Equity issued
Treasury shares at cost
Share- based payments and other reserves
Retained earnings
Accumulated other comprehensive income (loss)
[1]
Equity attributable to shareholders of Fairfax
Non- controlling interests
Multiple voting shares
Equity issued
Common shareholders’ equity
Equity issued
Preferred shares
Equity issued
Canada
Canada
Accumulated other comprehensive income (loss)
[1]
Canada
Equity attributable to shareholders of Fairfax
Canada
Common shareholders’ equity
Equity issued
Europe
Europe
Accumulated other comprehensive income (loss)
[1]
Europe
Equity attributable to shareholders of Fairfax
Europe
Common shareholders’ equity
Equity issued
European Run-off
Accumulated other comprehensive income (loss)
Beginning balance at Dec. 31, 2017 $ 18,412.0   $ (408.2) $ 194.5 $ 6,048.0 $ (264.1) $ 13,811.1 $ 4,600.9 $ 6,905.4 [2] $ 12,475.6 $ 1,335.5                  
Changes in equity [abstract]                                        
Net earnings (loss) for the year 817.9       376.0   376.0 441.9   376.0   $ 7.3                
Net unrealized foreign currency translation gains (losses) on foreign operations (661.2)         (459.0) (459.0) (202.2)   (459.0)                    
Gains (losses) on hedge of net investment                       166.3 $ 166.3 $ 166.3 $ 166.3 $ 57.1 $ 57.1 $ 57.1 $ 57.1  
Share of other comprehensive income (loss) of associates, excluding net gains (losses) on defined benefit plans (49.1)         (42.6) (42.6) (6.5)   (42.6)                    
Net gains (losses) on defined benefit plans 10.2 $ 9.9       9.9 9.9 0.3                        
Share of net gains (losses) on defined benefit plans of associates (44.0)         (42.2) (42.2) (1.8)   (42.2)                    
Issuances for share-based payments (0.6)   34.7 (35.3)     (0.6)     (0.6)                    
Purchases and amortization for share-based payments (note 16) (145.6)   (214.0) 66.1     (147.9) 2.3   (147.9)                    
Purchases for cancellation (note 16) (92.7)       (46.3)   (92.7)   46.4 [2] (92.7)                    
Common share dividends (442.7)       (283.2)   (283.2) (159.5)   (283.2)                    
Preferred share dividends (45.1)       (45.1)   (45.1)     (45.1)                    
Acquisitions of subsidiaries (note 23) (5.8)             (5.8)                        
Deconsolidation of subsidiary (note 23) (212.5)             (212.5)                        
Other net changes in capitalization (notes 16 and 23) (399.0)     (16.4) (185.2) 9.3 (192.3) (206.7)   (192.3)                    
Ending balance at Dec. 31, 2018 17,365.2   (587.5) 208.9 5,864.2 (565.3) 13,114.8 4,250.4 6,859.0 [2] 11,779.3 1,335.5                  
Changes in equity [abstract]                                        
Common stock, multiple voting shares, value                 3.8                      
Net earnings (loss) for the year 1,971.2       2,004.1   2,004.1 (32.9)   2,004.1   104.1                
Net unrealized foreign currency translation gains (losses) on foreign operations 101.4         118.3 118.3 (16.9)   118.3                    
Gains (losses) on hedge of net investment                       $ (105.6) $ (105.6) $ (105.6) $ (105.6) $ (35.3) $ (35.3) $ (35.3) $ (35.3)  
Share of other comprehensive income (loss) of associates, excluding net gains (losses) on defined benefit plans (37.7)         (17.6) (17.6) (20.1)   (17.6)                    
Net gains (losses) on defined benefit plans (69.3) $ (69.4)       (69.4) (69.4) 0.1                        
Share of net gains (losses) on defined benefit plans of associates (41.3)         (36.8) (36.8) (4.5)   (36.8)                    
Issuances for share-based payments (5.1)   30.8 (35.6)     (4.8) (0.3)   (4.8)                    
Purchases and amortization for share-based payments (note 16) (19.0)   (104.4) 80.1     (24.3) 5.3   (24.3)                    
Purchases for cancellation (note 16) (118.0)       (56.2)   (118.0)   61.8 [2] (118.0)                    
Common share dividends (453.8)       (278.0)   (278.0) (175.8)   (278.0)                    
Preferred share dividends (45.8)       (45.8)   (45.8)     (45.8)                    
Acquisitions of subsidiaries (note 23) 121.7             121.7                        
Deconsolidation of subsidiary (note 23) (466.2)             (466.2)                        
Other net changes in capitalization (notes 16 and 23) (255.2)     (14.4) (109.1)   (123.5) (131.7)   (123.5)                    
Ending balance at Dec. 31, 2019 $ 17,907.2   $ (661.1) $ 239.0 $ 7,379.2 $ (711.7) $ 14,378.1 $ 3,529.1 6,797.2 [2] $ 13,042.6 $ 1,335.5                 $ (127.5)
Changes in equity [abstract]                                        
Common stock, multiple voting shares, value                 $ 3.8                      
[1] Accumulated other comprehensive loss at December 31, 2019 of $711.7 included European Run-off's loss of $127.5 related primarily to net unrealized foreign currency translation losses (note 23).
[2] Includes multiple voting shares with a carrying value of $3.8 at January 1, 2018, December 31, 2018 and December 31, 2019.